Oncolet 2.5 mg Tablet
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Oncolet 2.5 mg Tablet

Oncolet 2.5 mg Tablet

Oncolet 2.5 mg Tablet contains letrozole, an aromatase inhibitor used mainly to treat hormone-sensitive breast cancer in postmenopausal women. It is an oral tablet taken according to the treatment plan prescribed by a qualified healthcare professional. Letrozole lowers estrogen production, helping slow or stop the growth of certain breast cancer cells.

BUY NOW

Category

Oncolet 2.5 mg Tablet is used for hormone receptor-positive early or advanced breast cancer in postmenopausal women. Letrozole inhibits the aromatase enzyme, reducing estrogen levels in the body and limiting estrogen stimulation of cancer cells. The tablet can generally be taken with or without food, as directed by the physician. Medical monitoring may include assessment of bone health and other treatment-related effects during long-term therapy.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer Zydus Lifesciences Limited

Product Also Known As

Oncolet 2.5 mg Tablet, Oncolet 2.5 Tablet, Oncolet Letrozole Tablet, Letrozole 2.5 mg Tablet, Letrozole Breast Cancer Tablet, Letrozole Aromatase Inhibitor Tablet